Healthtech Startups

Designs for Health (DFH) develops and sells professional-grade dietary supplements, including probiotics and functional testing, aimed at licensed practitioners and their patients. It provides practitioner tools such as a virtual dispensary, Spotlight testing, eScripting, and consultant support alongside direct-to-consumer supplement plans.

1 investor

Detective Biosciences is developing a blood-based cancer detection test that analyzes patients' DNA epigenetic profiles. The company operates in the cancer diagnostics and biotech space.

1 investor

DeuterOncology is a clinical-stage biotech developing DO-2, a deuterated, brain-penetrant MET kinase and RAS pathway inhibitor for cancer patients, currently in a phase 1 clinical study. The molecule was in-licensed from OCTIMET Oncology and originally from Janssen Pharmaceutica.

1 investor

Deviceflow reads the unstructured inputs that medical device field teams already send — emails, photos, texts, charge sheets, and POs — extracts the data, and writes structured records into the company's ERP, GL, and CRM. It targets medical device distributors and manufacturers, automating bill-only matching, purchase order processing, inventory tracking, case coordination, and compliance.

1 investor

SubioMed develops Suspension Biomechanics, a patented technology platform that manages ground reaction forces to control motion during gait, aiming to reduce pain, improve function, and prevent lower-extremity injuries and pathologies. The technology is applied to medical and consumer products such as orthotic inserts, bracing and supports, walking boots, and footwear.

1 investor

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.

1 investor

Dexterous Endoscopes, an EPFL spin-off, develops endoscopes with variable stiffness for minimally invasive surgical procedures. Its first product targets ear, nose, and throat (ENT) surgeries, enabling new sinus and larynx procedures in hard-to-reach areas.

1 investor

Dezhen Technology provides information technology solutions and IT strategy consulting for hospitals and medical institutions, covering clinical care, research, and management. Services include hospital IT strategy design, implementation planning, information system deployment, and staff training for information management departments.

1 investor

Dharmalife is a social impact organisation founded in 2009 that trains rural women in India as entrepreneurs (Dharma Life Entrepreneurs) to distribute socially impactful products and services to rural households. It operates through a not-for-profit, a foundation, and a for-profit last-mile distribution arm, focusing on livelihoods, behaviour change, and women's economic independence in rural India.

1 investor

Dharmacon Reagents provides synthetic oligonucleotides, gene modulation, and gene editing solutions for functional genomics research, enabling researchers to study genetic networks and advance therapeutic discovery. The company offers a comprehensive range of tools for DNA, RNA, and protein-level research, including RNAi, CRISPR gene editing, and screening libraries for academic and commercial researchers.

1 investor

DHNY organizes events and content sharing platforms that connect professionals in the digital health industry to exchange innovations and ideas.

1 investor

DiabeTech develops an AI-powered biosensor sock and mobile platform to detect diabetic foot complications and ulcers at an early stage, serving patients and healthcare providers. The company operates in the digital health and medical device space, partnering with healthcare systems and clinics across the United States.

1 investor

A nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.

1 investor

ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.

1 investor

Diabettech is an information resource about diabetes technology, covering CGM systems, DIY closed-loop insulin delivery, and emerging insulins through blog posts, guides, and user studies. It also runs a fee-free marketplace for exchanging looping supplies such as pumps and CGM components.

1 investor

Diaceutics provides intelligence and engagement solutions that help biopharma companies commercialize precision medicine and diagnostic-driven therapies, using data from US labs to identify eligible patients and engage the physicians and labs involved in testing and treatment decisions. It serves pharmaceutical and biopharma teams across pre-launch, launch and in-market stages, primarily in the US diagnostics and precision medicine market.

1 investor

Diadia is an AI platform for functional medicine clinicians that automatically synthesizes patient lab results, gut tests, metabolites, and genetics into structured reports modeled on each clinician's own dosing rules, interpretation logic, and clinical frameworks. It reduces between-visit administrative work and is offered free to clinicians, with patients paying for diagnostics through the platform.

1 investor

1 investor

Diagnóstica Longwood is a distributor of in vitro diagnostics technologies, supplying NGS-based assays, kits and reagents for molecular diagnostics in areas such as oncology, hereditary and rare diseases, and microbiology. Founded in 1992, it serves clinical and research laboratories with technical support and its own inventory in Spain.

1 investor

Diagnostic Imaging is an online media outlet publishing news, research summaries, podcasts, and video interviews focused on radiology and medical imaging. It covers topics such as AI in radiology, imaging modalities (MRI, CT, PET, ultrasound), and clinical developments for radiologists and imaging professionals.

1 investor

DIAGNOSTYKA operates a network of medical sample collection points and offers laboratory tests and test packages, including online purchase, results retrieval, and online consultations. It serves patients in Poland seeking diagnostic laboratory testing.

1 investor

Backline is a healthcare communication and coordination platform that helps hospital teams manage clinical workflows like care coordination, consults, patient engagement, and case management. Part of DrFirst, it provides task accountability and escalation features built on secure messaging infrastructure trusted by 1,500+ healthcare facilities.

1 investor

Diamante develops plant-based compounds for therapeutic and diagnostic systems targeting autoimmune diseases. The company applies molecular farming techniques to produce biopharmaceuticals and aims to advance treatments from research to clinical applications.

1 investor

Diamidex develops microbiological analysis solutions for water safety, including equipment, software, and reagents designed to detect and count targeted microorganisms with improved speed and accuracy for laboratory use.

1 investor